1 | EVKA CONSULTZ LTD | 12825 | EZURA® 10mg F/C Tablets | Human | Foreign | Escitalopram Oxalate USP Equivalent to
| Each film coated tablet contains; Escitalopram
| H2019/CTD6534/12825 | Film-Coated Tablet | ORAL | Recommended | 24 months | White to off white oval biconvex tablet scored
| N06AB10 | escitalopram | United Pharmaceutical Mfg. Co Ltd | Nuzhat Sahab, Al-Raqeem- Near public security
| Info@upm.com.jo | UNITED PHARMACEUTICAL MFG. CO. LTD | P.O. BOX 69 AMMAN 11591 JORDAN | Registered | Valid |
2 | LORDS HEALTHCARE LTD | 12889 | I-FREE | Human | Foreign | MIFEPRISTONE & MISOPROSTOL BP | 200MG & 200MCG | H2019/CTD6622/12889 | Tablet | ORAL | Recommended | 24 months | MIFEPRISTONE TABLET-LIGHT YELLOWCOLOURED, ROUND,
| G03XB51 | mifepristone combinations | LORDS HEALTHCARE LTD. | CAPITOL HILL TOWERS, CATHEDRAL ROAD, 49397-00100
| lords@swiftkenya.com | SYNOKEM PHARMACEUTICALS LTD | PLOT 35-36 SECTOR 6A, INTERGRATED INDUSTRIAL
| Registered | Valid |
3 | LORDS HEALTHCARE LTD | 13102 | TENGLIPT-M | Human | Foreign | TENELIGLIPTIN HYDROBROMIDE HYDRATE & METFORMIN
| 20MG/500MG | H2019/CTD6749/13102 | Tablet | ORAL | Recommended | 24 months | ONE SIDE WHITE, OTHER SIDE YELLOW COLOURED,
| A10BD | Combinations of oral blood glucose lowering drugs | LORDS HEALTHCARE LTD | CAPITOL HILL TOWERS, CATHEDRAL ROAD, 49397-00100
| lords@swiftkenya.com | SYNOKEM PHARMACEUTICALS LTD. | 100000000000204
| Registered | Valid |
4 | HASSCON PHARMACEUTICALS LTD | 13331 | ESOMCON 20 | Human | Foreign | Esomeprazole Magnesium Trihydrate BP | 20MG | H2019/CTD6986/13331 | Coated Tablet | ORAL | Recommended | 24 months | Brown coloured, round shaped, biconvex, enteric
| A02BC05 | esomeprazole | RATNAMANI HEALTHCARE PRIVATE LIMITED | Survey No. : 750/1 , Ahmedabad Mehsana Highway ,
| info@rhc9.in | RATNAMANI HEALTHCARE PVT LTD | SURVEY NO. 750/1, AHMEDSBSD MEHSANA HIGHWAY,
| Registered | Valid |
5 | EVKA CONSULTZ LTD | 13390 | BETOLINA 100mg/20ml Solution for Injection | Human | Foreign | Bupivacaine Hydrochloride EP | Each 1ml contains: Bupivacaine Hydrochloride 5mg | H2019/CTD6902/13390 | Solution For Injection | INTRAVENOUS | Recommended | 24 months | Clear and colourless solution. | N01BB01 | bupivacaine | MS Pharma Jordan | King Abdulla (II) Bin Al-Hussein Industrial Estate | dina.abukhalaf@mspharma.com | MS PHARMA JORDAN | MS PHARMA JORDAN | Registered | Valid |
6 | EVKA CONSULTZ LTD | 13392 | SEDALAM 15mg/3ml Solution for Injection | Human | Foreign | Midazolam USP | Midazolam USP | H2019/CTD6904/13392 | Solution For Injection | INTRAVENOUS | Recommended | 24 months | Clear and colourless solution | N05CD08 | midazolam | MS Pharma Jordan | King Abdulla (II) Bin Al-Hussein Industrial
| dina.abukhalaf@mspharma.com | MS PHARMA JORDAN | MS PHARMA JORDAN | Registered | Valid |
7 | EVKA CONSULTZ LTD | 13395 | PARAVIN 1000mg/100ml Solution for Infusion | Human | Foreign | Paracetamol EP | Each ml contains: Paracetamol EP……..10mg | H2019/CTD6905/13395 | Solution For Infusion | INTRAVENOUS | Recommended | 24 months | Clear and colourless solution. | N02BE01 | paracetamol | MS Pharma Jordan | King Abdulla (II) Bin Al-Hussein Industrial
| dina.abukhalaf@mspharma.com | MS PHARMA JORDAN | MS PHARMA JORDAN | Registered | Valid |
8 | RIPPLE PHARMACEUTICALS LTD | 13734 | Trastuzumab 440mg | Human | Foreign | Trastuzumab | 440 mg | H2019/CTD7100/13734 | Solution For Infusion | INTRAVENOUS | Recommended | 24 months | | L01XC03 | trastuzumab | CADILA HEALTHCARE LIMITED | Zydus Tower, Satellite Cross Roads, Ahmedabad 380
| Kajal.Sharma@zyduscadila.com | CADILA HEALTHCARE LTD | SURVEY NO. 23, 25/P, 37, 40/P, 42 TO 47,
| Registered | Valid |
9 | RIPPLE PHARMACEUTICALS LTD | 13758 | Bevacizumab 400mg | Human | Foreign | Bevacizumab | 400 mg | H2019/CTD7107/13758 | Concentrate For Solution For Infusion | INTRAVENOUS | Recommended | 24 months | | L01XC07 | bevacizumab | CADILA HEALTHCARE LIMITED | Zydus Tower, Satellite Cross Roads, Ahmedabad 380
| Kajal.Sharma@zyduscadila.com | CADILA HEALTHCARE LTD | SURVEY NO. 23, 25/P, 37, 40/P, 42 TO 47,
| Registered | Valid |
10 | RIPPLE PHARMACEUTICALS LTD | 13759 | Bevacizumab 100mg | Human | Foreign | Bevacizumab | 100mg | H2019/CTD7108/13759 | Concentrate For Solution For Infusion | INTRAVENOUS | Recommended | 24 months | | L01XC07 | bevacizumab | CADILA HEALTHCARE LIMITED | Zydus Tower, Satellite Cross Roads, Ahmedabad 380
| Kajal.Sharma@zyduscadila.com | CADILA HEALTHCARE LTD | SURVEY NO. 23, 25/P, 37, 40/P, 42 TO 47,
| Registered | Valid |